191 related articles for article (PubMed ID: 26891695)
1. Differential localization of A-Raf regulates MST2-mediated apoptosis during epithelial differentiation.
Rauch J; Vandamme D; Mack B; McCann B; Volinsky N; Blanco A; Gires O; Kolch W
Cell Death Differ; 2016 Aug; 23(8):1283-95. PubMed ID: 26891695
[TBL] [Abstract][Full Text] [Related]
2. Spatial regulation of ARAF controls the MST2-Hippo pathway.
Rauch J; Kolch W
Small GTPases; 2019 Jul; 10(4):243-248. PubMed ID: 28281933
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription.
Rauch J; O'Neill E; Mack B; Matthias C; Munz M; Kolch W; Gires O
Cancer Res; 2010 Feb; 70(4):1679-88. PubMed ID: 20145135
[TBL] [Abstract][Full Text] [Related]
4. Taming the Hippo: Raf-1 controls apoptosis by suppressing MST2/Hippo.
O'Neill E; Kolch W
Cell Cycle; 2005 Mar; 4(3):365-7. PubMed ID: 15701972
[TBL] [Abstract][Full Text] [Related]
5. A-Raf: A new star of the family of raf kinases.
An S; Yang Y; Ward R; Liu Y; Guo XX; Xu TR
Crit Rev Biochem Mol Biol; 2015; 50(6):520-31. PubMed ID: 26508523
[TBL] [Abstract][Full Text] [Related]
6. Proapoptotic kinase MST2 coordinates signaling crosstalk between RASSF1A, Raf-1, and Akt.
Romano D; Matallanas D; Weitsman G; Preisinger C; Ng T; Kolch W
Cancer Res; 2010 Feb; 70(3):1195-203. PubMed ID: 20086174
[TBL] [Abstract][Full Text] [Related]
7. Role of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1.
O'Neill E; Rushworth L; Baccarini M; Kolch W
Science; 2004 Dec; 306(5705):2267-70. PubMed ID: 15618521
[TBL] [Abstract][Full Text] [Related]
8. c-Myc regulates RNA splicing of the A-Raf kinase and its activation of the ERK pathway.
Rauch J; Moran-Jones K; Albrecht V; Schwarzl T; Hunter K; Gires O; Kolch W
Cancer Res; 2011 Jul; 71(13):4664-74. PubMed ID: 21512137
[TBL] [Abstract][Full Text] [Related]
9. Mammalian Ste20-like kinase (Mst2) indirectly supports Raf-1/ERK pathway activity via maintenance of protein phosphatase-2A catalytic subunit levels and consequent suppression of inhibitory Raf-1 phosphorylation.
Kilili GK; Kyriakis JM
J Biol Chem; 2010 May; 285(20):15076-15087. PubMed ID: 20212043
[TBL] [Abstract][Full Text] [Related]
10. DA-Raf-Mediated Suppression of the Ras--ERK Pathway Is Essential for TGF-β1-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial Type 2 Cells.
Watanabe-Takano H; Takano K; Hatano M; Tokuhisa T; Endo T
PLoS One; 2015; 10(5):e0127888. PubMed ID: 25996975
[TBL] [Abstract][Full Text] [Related]
11. The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration.
Klingauf M; Beck M; Berge U; Turgay Y; Heinzer S; Horvath P; Kroschewski R
Biol Cell; 2013 Feb; 105(2):91-107. PubMed ID: 23157514
[TBL] [Abstract][Full Text] [Related]
12. Human alphaA- and alphaB-crystallins prevent UVA-induced apoptosis through regulation of PKCalpha, RAF/MEK/ERK and AKT signaling pathways.
Liu JP; Schlosser R; Ma WY; Dong Z; Feng H; Liu L; Huang XQ; Liu Y; Li DW
Exp Eye Res; 2004 Sep; 79(3):393-403. PubMed ID: 15336502
[TBL] [Abstract][Full Text] [Related]
13. Cot protooncoprotein activates the dual specificity kinases MEK-1 and SEK-1 and induces differentiation of PC12 cells.
Hagemann D; Troppmair J; Rapp UR
Oncogene; 1999 Feb; 18(7):1391-400. PubMed ID: 10050876
[TBL] [Abstract][Full Text] [Related]
14. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways.
Grana TM; Rusyn EV; Zhou H; Sartor CI; Cox AD
Cancer Res; 2002 Jul; 62(14):4142-50. PubMed ID: 12124353
[TBL] [Abstract][Full Text] [Related]
15. Raf-1 signaling is required for the later stages of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells but is not mediated by the MEK/ERK module.
Wang X; Studzinski GP
J Cell Physiol; 2006 Nov; 209(2):253-60. PubMed ID: 16883571
[TBL] [Abstract][Full Text] [Related]
16. LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer.
Vakana E; Pratt S; Blosser W; Dowless M; Simpson N; Yuan XJ; Jaken S; Manro J; Stephens J; Zhang Y; Huber L; Peng SB; Stancato LF
Oncotarget; 2017 Feb; 8(6):9251-9266. PubMed ID: 27999210
[TBL] [Abstract][Full Text] [Related]
17. RAF protein-serine/threonine kinases: structure and regulation.
Roskoski R
Biochem Biophys Res Commun; 2010 Aug; 399(3):313-7. PubMed ID: 20674547
[TBL] [Abstract][Full Text] [Related]
18. Mammalian sterile 20-like kinases in tumor suppression: an emerging pathway.
O'Neill EE; Matallanas D; Kolch W
Cancer Res; 2005 Jul; 65(13):5485-7. PubMed ID: 15994916
[TBL] [Abstract][Full Text] [Related]
19. MST2 silencing induces apoptosis and inhibits tumor growth for estrogen receptor alpha-positive MCF-7 breast cancer.
Park J; Kim GH; Lee J; Phuong BTC; Kong B; Won JE; Won GW; Lee YH; Han HD; Lee Y
Toxicol Appl Pharmacol; 2020 Dec; 408():115257. PubMed ID: 33007383
[TBL] [Abstract][Full Text] [Related]
20. RGS19 inhibits Ras signaling through Nm23H1/2-mediated phosphorylation of the kinase suppressor of Ras.
Tso PH; Wang Y; Yung LY; Tong Y; Lee MM; Wong YH
Cell Signal; 2013 May; 25(5):1064-74. PubMed ID: 23416464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
